Publications by authors named "Peter Ljubenkov"

Claim this Profile
B
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance.
Igor Prufer Q C Araujo, Tara Ellingson, Nicholas U Schwartz, Connor D Dietz, Gautam Tammewar, Peter A Ljubenkov

Alzheimers Dement· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations.
Yohannes A Ambaw, Peter A Ljubenkov, Shubham Singh, Abdi Hamed, Sebastian Boland

Alzheimers Dement· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.
Nicholas U Schwartz, Connor D Dietz, Igor Prufer Araújo, Javier E Villanueva-Meyer, Winston Chiong, Peter A Ljubenkov

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
Rowan Saloner, Adam M Staffaroni, Eric B Dammer, Erik C B Johnson, Emily W Paolillo, Peter A Ljubenkov

Nat Aging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
Rowan Saloner, Adam M Staffaroni, Eric B Dammer, Erik C B Johnson, Emily W Paolillo, Peter A Ljubenkov

Nat Aging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials.
Mark Sanderson-Cimino, Katherine L Possin, Dan M Mungas, Emily W Paolillo, Breton M Asken, Peter Ljubenkov

J Int Neuropsychol Soc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.
Lawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, Fattin Wekselman, Yann Cobigo, Peter Ljubenkov

JAMA Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S Mundada, Mary Koestler, Peter A Ljubenkov

Acta Neuropathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and neuropathological associations of plasma Aβ/Aβ, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders.
Binita Rajbanshi, Igor Prufer Q C Araujo, Lawren VandeVrede, Peter A Ljubenkov, Adam M Staffaroni

Alzheimers Dement (Amst)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy.
Ashlin R K Roy, Fate Noohi, Nathaniel A Morris, Peter Ljubenkov, Hilary Heuer

Neuroimage Clin· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF Proteomics in Patients With Progressive Supranuclear Palsy.
Amy Wise, Jingyao Li, Mai Yamakawa, Joseph Loureiro, Brant Peterson, Peter A Ljubenkov

Neurology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
Indira Garcia-Cordero, Chloe Anastassiadis, Abeer Khoja, Alonso Morales-Rivero, Simrika Thapa, Peter Ljubenkov

Ann Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort.
Niyatee Samudra, D Luke Fischer, Steven Lenio, Argentina Lario Lago, Peter A Ljubenkov

Alzheimers Dement· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
Rowan Saloner, Adam Staffaroni, Eric Dammer, Erik C B Johnson, Emily Paolillo, Peter Ljubenkov

Res Sq· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
Ganna Blazhenets, David N Soleimani-Meigooni, Wesley Thomas, Nidhi Mundada, Matthias Brendel, Peter Ljubenkov

J Nucl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S Mundada, Mary Koestler, Peter A Ljubenkov

Acta Neuropathol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration.
Breton M Asken, Peter A Ljubenkov, Adam M Staffaroni, Kaitlin B Casaletto, Lawren Vandevrede

J Neurol Neurosurg Psychiatry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing tau to treat early Alzheimer's disease.
Peter A Ljubenkov, Gil D Rabinovici

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome.
Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, Breton M Asken, Stephanie A Vento, Peter A Ljubenkov

JAMA Neurol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal order of clinical and biomarker changes in familial frontotemporal dementia.
Adam M Staffaroni, Melanie Quintana, Barbara Wendelberger, Hilary W Heuer, Lucy L Russell, Peter Ljubenkov

Nat Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.
Gianina Toller, Yann Cobigo, Peter A Ljubenkov, Brian S Appleby, Bradford C Dickerson

Neurology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Novel Variant in a Patient With Behavioral Variant Frontotemporal Dementia Syndrome With Prodromal Repetitive Scratching Behavior.
Adit Friedberg, Eliana Marisa Ramos, Zhongan Yang, Luke W Bonham, Jennifer S Yokoyama, Peter A Ljubenkov

Front Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
Niklas Mattsson-Carlgren, Lea T Grinberg, Adam Boxer, Rik Ossenkoppele, Magnus Jonsson, Peter Ljubenkov

Neurology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.
Peter A Ljubenkov, Lauren Edwards, Leonardo Iaccarino, Renaud La Joie, Julio C Rojas

JAMA Netw Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.
Brent Bluett, Alexander Y Pantelyat, Irene Litvan, Farwa Ali, Diana Apetauerova, Peter Alexander Ljubenkov

Front Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis